Topaloglu, O. Et Al. 2019. Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin. ISTANBUL MEDICAL JOURNAL , vol.20, no.2 , 169-171.

Topaloglu, O., EVREN, B., & ŞAHİN, İ., (2019). Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin. ISTANBUL MEDICAL JOURNAL , vol.20, no.2, 169-171.

Topaloglu, Omercan, BAHRİ EVREN, And İBRAHİM ŞAHİN. "Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin," ISTANBUL MEDICAL JOURNAL , vol.20, no.2, 169-171, 2019

Topaloglu, Omercan Et Al. "Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin." ISTANBUL MEDICAL JOURNAL , vol.20, no.2, pp.169-171, 2019

Topaloglu, O. EVREN, B. And ŞAHİN, İ. (2019) . "Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin." ISTANBUL MEDICAL JOURNAL , vol.20, no.2, pp.169-171.

@article{article, author={Omercan Topaloglu Et Al. }, title={Palpable Purpura in a Patient with Uncontrolled Type 2 Diabetes Mellitus: Possible Side Effect of Linagliptin}, journal={ISTANBUL MEDICAL JOURNAL}, year=2019, pages={169-171} }